Dr. Sharon Cohen Vered

Advisory Board Member

Sharon Cohen Vered is a development and operations executive with over 25 years of experience leading drug development (CMC) teams in the pharmaceutical industry, both in large multinational corporations as well as in startup environments.

Prior roles include VP CMC at NeuroDerm for 10 years, CMC at Orasis Pharmaceutical, and Head of Parenteral Dosage Forms at Teva innovative R&D for 15 years, Sharon has also been consulting many pharmaceutical companies over the past 12 years.

PhD in Biochemistry from Tel Aviv University